FIELD: food industry.
SUBSTANCE: invention relates to the field of medicine, biology, prevention of the human diseases and health preservation. The substances composition for impact on the microbial-tissular complex of the human bowel is represented by a complex target product. The product includes inactivated yeast cytoskeletons. The yeast is represented by Saccharomyces symbiotic races mixture immobilised on a carrier. The carrier is produced depending on the composition of a mixture of offal of cereals and/or legumes and/or nuts by way of their extrusion under a pressure up to 300 kg/cm2 and at a temperature of 80 - 220°C combined with drinking water in a proportion equal to 1 kg of the mixture per 0.5-2.0 l of drinking water. Additionally the complex target product includes Saccharomyces symbiotic races vital activity products biomass at a ratio of 15 - 85 % of the Saccharomyces biomass total quantity. The physical and chemical composition of the product is determined according to presence of microelements and/or enzymes and/or hormones introduced in the process of Saccharomyces biomass growth on the carrier as well as according to presence of oligosaccharides in the carrier composition equal to less than 50% of the total content of carbohydrates contained in the carrier. The vital activity products biomass combined with microelements and/or enzymes and/or hormones, produced as a result of their processing by Saccharomyces on extruded offal of cereals and/or legumes and/or nuts having a porous surface no less than 2.0 m2/g and with Saccharomyces cells concentration equal to no less than 103-1012 cells/g, is represented by a biotransformed compound. This compound provides for presence of element compound as follows in the target product, wt %: carbon - no less than 45, hydrogen - no less than 6.4, oxygen - no less than 30, nitrogen - 7.5-10, phosphorus -1.6-3.5, calcium - 0.3-0.8, potassium - 1.5-2.5, magnesium - 0.1-0.4, sodium - 0.06-0.2, sulphur - 0.2% as well as presence of biotransformed yeast microelements in the biotransformed compound which include, mg/kg: ferrum - 90- 350, cuprum - 20-135, zinc - 100-160, molybdenum - 15-65. The biotransformed compound presence in the substances composition ensures adaptogenic, immunomodulatory, metabolic-homeostasing, enterosorption, detoxification and antiinflammatory activity under impact on the bowel microbial-tissular complex with persons suffering from acute and chronic diseases as well as persons having undergone environmental impact.
EFFECT: invention allows to recover the microbial-tissular complex of the human bowel in general.
4 cl, 7 dwg, 1 tbl, 12 ex
